Refractory Angioimmunoblastic T-Cell Lymphoma

Explore clinical trials studying Refractory Angioimmunoblastic T-Cell Lymphoma. Study availability and eligibility vary by location and protocol.

5 public trials 1 recruiting study

Refine in advanced search Browse all conditions

Refractory Angioimmunoblastic T-Cell Lymphoma trial results

Recruiting

NCT03017820

Conditions: B-Cell Non-Hodgkin Lymphoma, Blood Protein Disorders, Bone Marrow Diseases, +46 more
Locations: Mayo Clinic in Arizona Scottsdale, Arizona, United States

Mayo Clinic in Rochester Rochester, Minnesota, United States

Completed

NCT03593018

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoblastic Lymphadenopathy, +6 more
Locations: University Hospital for Internal Medicine - University Hospital Graz Graz, Austria

Medical University of Vienna Vienna, Austria

A. Z. Sint-Jan Brugge-Oostende AV Bruges, Belgium

Cliniques Universitaires de Bruxelles - Hôpital Erasme Brussels, Belgium

View all 27 locations

Completed

NCT01590732

Conditions: Enteropathy-Associated T-Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +23 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

Active, Not Recruiting

NCT03598998

Conditions: Anaplastic Large Cell Lymphoma, Enteropathy-Associated T-Cell Lymphoma, Hemic and Lymphatic Diseases, +35 more
Locations: City of Hope Medical Center Duarte, California, United States

Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States

University of Nebraska Medical Center Omaha, Nebraska, United States

Active, Not Recruiting

NCT03278782

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoblastic Lymphadenopathy, +23 more
Locations: M D Anderson Cancer Center Houston, Texas, United States